Back to Home
Event on : Monday, Nov 22, 2021

Cancer Conversations™ Application of Individualized Treatment for MDS: Expert Guidance for Clinical Practice

In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxicity and the use of NRTI-sparing regimens with discussion of the GEMINI-1 and -2 studies of DTG/3TC and the SWORD-1 and -2 studies of DTG/RPV, and safety with long-acting injectables with specific discussion of the ATLAS and FLAIR studies

Ursula Matulonis, MD

Program Director

Robert L. Coleman, MD, FACOG,

FACS

CME Activities Required : 3

Claim Credit

Claim your credit
Credits Available for this Module

Physician – AMA - 11 Credit(s)

Advanced Practice Nurse – ANCC - 11 Credit(s)

Physician assistant – AAPA - 2.50 Hour(s)

Nurse – ANCC 1 Credit(s)

Pretest

Step

1 2 3 4
Course Completed
Jacob , please answer the questions
01. Which of the following is true of patients with allergicconjunctivitis?
02. Which of the following topical ophthalmic treatments are available over the counter?
03. How often do you advise patients to keep a diary recording possible triggers for their itchy eyes?
04. Once you have identified allergic conjunctivitis, if allergen avoidance and lubricant drops are inadequate, how often do you suggest dual-activity eye drops?
Next